Flagship explainer
What drives TG THERAPEUTICS, INC.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| $447M | FY2025 |
| |
| Income before tax | $107M | FY2025 |
|
| Operating income | $123M | FY2025 |
|
| $616M | FY2025 |
| |
| Ending assets | $1.1B | FY2025 |
|
| Beginning assets | $578M | FY2024 |
|
| $648M | FY2025 |
| |
| $222M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001437749-26-006133